Jens Lundgren

61.6k total citations · 9 hit papers
678 papers, 33.1k citations indexed

About

Jens Lundgren is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Jens Lundgren has authored 678 papers receiving a total of 33.1k indexed citations (citations by other indexed papers that have themselves been cited), including 376 papers in Infectious Diseases, 241 papers in Epidemiology and 196 papers in Emergency Medicine. Recurrent topics in Jens Lundgren's work include HIV/AIDS drug development and treatment (258 papers), HIV/AIDS Research and Interventions (222 papers) and HIV-related health complications and treatments (187 papers). Jens Lundgren is often cited by papers focused on HIV/AIDS drug development and treatment (258 papers), HIV/AIDS Research and Interventions (222 papers) and HIV-related health complications and treatments (187 papers). Jens Lundgren collaborates with scholars based in Denmark, United Kingdom and United States. Jens Lundgren's co-authors include Ole Kirk, Amanda Mocroft, Andrew Phillips, Antonella d’Arminio Monforte, Peter Reiss, Bruno Ledergerber, Caroline Sabin, Matthew Law, Thomas Benfield and Christine Katlama and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jens Lundgren

667 papers receiving 32.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

2008 1.2k citations Bruno Ledergerber, Jens Lundgren et al. profile →
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

2002 1.2k citations Bruno Ledergerber, Peter Reiss et al. profile →
Changing patterns of mortality across Europe in patients infected with HIV-1

1998 1.0k citations Amanda Mocroft, AN Phillips et al. profile →
Decline in the AIDS and death rates in the EuroSIDA study: an observational study

2003 989 citations Amanda Mocroft, Bruno Ledergerber et al. profile →
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

2003 802 citations Nina Friis‐Møller, Rainer Weber et al. AIDS profile →
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

2016 693 citations Jens Lundgren et al. Clinical Infectious Diseases profile →
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

2014 689 citations Rainer Weber, Peter Reiss et al. profile →
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

2009 481 citations Caroline Sabin, Rainer Weber et al. The Journal of Infectious Diseases profile →
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

2012 419 citations Bruno Ledergerber, Jens Lundgren et al. profile →

Peers

Countries citing papers authored by Jens Lundgren

Since Specialization

Citations

This map shows the geographic impact of Jens Lundgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Lundgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Lundgren more than expected).

Fields of papers citing papers by Jens Lundgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Lundgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Lundgren. The network helps show where Jens Lundgren may publish in the future.

Co-authorship network of co-authors of Jens Lundgren

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Lundgren. A scholar is included among the top collaborators of Jens Lundgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Lundgren. Jens Lundgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19 2025 ·BMC Infectious Diseases ·Catharine I. Paules, (unknown), Kathryn Shaw‐Saliba, Judith A. Aberg, Edward M. Gardner, Anna L. Goodman, Nagalingeswaran Kumarasamy, (unknown), David M. Vock, Crystal M. North, Jens Lundgren, Neil R. Aggarwal, (unknown)	2
2	Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade 2024 ·European Journal Of Haematology ·(unknown), Joanne Reekie, Henrik Sengeløv, Caspar da Cunha‐Bang, Thomas Kromann Lund, (unknown), (unknown), (unknown), (unknown), Jens Lundgren, (unknown)	7
3	Management of Post-transplant Infections in Collaborating Hospitals (MATCH) Programme: a prospective cohort of all transplant recipients at Copenhagen University Hospital—Rigshospitalet, Denmark 2024 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), (unknown), Finn Gustafsson, Henrik Sengeløv, Michael Perch, Nicolai Aagaard Schultz, Søren Schwartz Sørensen, Jesper Melchior Hansen, Vibeke Brix Christensen, Daniel D. Murray, Jens Lundgren, C. Crone, Marie Helleberg	1
4	Deployment and validation of the CLL treatment infection model adjoined to an EHR system 2024 ·npj Digital Medicine ·Rudi Agius, Anders C. Riis-Jensen, (unknown), Caspar da Cunha‐Bang, Daniel D. Murray, Christian Bjørn Poulsen, (unknown), (unknown), Jens Lundgren, Henning Langberg, Carsten Utoft Niemann	3
5	Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort 2023 ·AIDS ·(unknown), Marc Bennedbæk, (unknown), Miglė Gabrielaitė, Preston Leung, Mark N. Polizzotto, Virginia L. Kan, Daniel D. Murray, Jens Lundgren, Cameron Ross MacPherson	1
6	Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function 2023 ·Frontiers in Immunology ·Dina Leth Møller, Søren Schwartz Sørensen, Omid Rezahosseini, (unknown), (unknown), (unknown), Michael Perch, Finn Gustafsson, Jens Lundgren, Thomas Scheike, Jenny Dahl Knudsen, Sisse Rye Ostrowski, Allan Rasmussen, Susanne Dam Nielsen	2
7	Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality 2023 ·Clinical Oncology ·(unknown), (unknown), (unknown), Abraham George Smith, Jens Petersen, Marie Helleberg, Jens Lundgren, (unknown), (unknown)	10
8	Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study 2023 ·HIV Medicine ·Alessandro Cozzi‐Lepri, David Dunn, Anna Tostevin, Rasmus L. Marvig, Marc Bennedbæk, Shweta Sharma, Michael D. Miller, Mark Gompels, Angie N. Pinto, Jens Lundgren, John D. Baxter, (unknown)	2
9	Differences in toll‐like receptor ligand‐induced cytokine concentrations before and after solid organ transplantation: A prospective, observational cohort study in a clinical setting 2023 ·Scandinavian Journal of Immunology ·Dina Leth Møller, Søren Schwartz Sørensen, Michael Perch, Finn Gustafsson, (unknown), Andreas Dehlbæk Knudsen, (unknown), (unknown), Jens Lundgren, Allan Rasmussen, Sisse Rye Ostrowski, Susanne Dam Nielsen	0
10	Incidence and Impact of Parvovirus B19 Infection in Seronegative Solid Organ Transplant Recipients 2021 ·The Journal of Infectious Diseases ·Omid Rezahosseini, (unknown), Dina Leth Møller, Søren Schwartz Sørensen, (unknown), Michael Perch, Finn Gustafsson, Allan Rasmussen, Nikolai Kirkby, Joanne Reekie, Jens Lundgren, Susanne Dam Nielsen	6
11	Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps 2021 ·HIV Medicine ·Christian Kraef, (unknown), (unknown), Amanda Mocroft, Lars Peters, Jens Lundgren, Nikoloz Chkhartishvili, Daria Podlekareva, Ole Kirk	10
12	Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017 2020 ·SHILAP Revista de lepidopterología ·Marie Helleberg, Daniel Cho, (unknown), Søren Schwartz Sørensen, Marianne Rix, Finn Gustafsson, Allan Rasmussen, Michael Perch, Peter Henrik Andersen, Jens Lundgren, Åse Bengård Andersen	6
13	Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation 2020 ·Clinical Infectious Diseases ·Omid Rezahosseini, Søren Schwartz Sørensen, Michael Perch, (unknown), Dina Leth Møller, Andreas Dehlbæk Knudsen, Nikolai Kirkby, Jens Lundgren, (unknown), (unknown), Finn Gustafsson, Allan Rasmussen, Susanne Dam Nielsen	10
14	Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients 2019 ·Open Forum Infectious Diseases ·Mark P. Khurana, (unknown), Amanda Mocroft, Søren Schwartz Sørensen, Michael Perch, Allan Rasmussen, Finn Gustafsson, Jens Lundgren	28
15	Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing 2019 ·Scientific Reports ·(unknown), Mette Jørgensen, Marc Noguera-Julián, Gedske Daugaard, Daniel D. Murray, Marie Helleberg, Roger Paredes, Jens Lundgren, Henrik Sengeløv, Cameron Ross MacPherson	22
16	Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model 2018 ·Critical Care and Resuscitation ·Theis Skovsgaard Itenov, Rasmus Ehrenfried Berthelsen, Jens‐Ulrik Stæhr Jensen, Thomas Alexander Gerds, Lars Møller Pedersen, Ditte Gry Strange, Katrín Þormar, Jesper Løken, Mads Andersen, Hamid Tousi, Nanna Reiter, Jens Lundgren, Morten H. Bestle	14
17	Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls 2018 ·UCL Discovery (University College London) ·Andreas Dehlbæk Knudsen, Marco Gelpi, Shoaib Afzal, Andreas Ronit, Ashley Roen, Amanda Mocroft, Jens Lundgren, Børge G. Nordestgaard, Henrik Sillesen, (unknown), Lars Køber, Klaus F. Kofoed, Susanne Dam Nielsen	3
18	Antiretroviral drugs and the risk of myocardial infarction - Reply 2007 ·UCL Discovery (University College London) ·Caroline Sabin, Nina Friis‐Møller, Jens Lundgren, (unknown)	2
19	Safety of non-nucleoside reverse transcriptase therapy: data from the EuroSIDA study 2003 ·UCL Discovery (University College London) ·Nina Friis‐Møller, Ole Kirk, Peter Reiss, (unknown), Christine Katlama, (unknown), Dénes Bánhegyi, Josep M. Gatell, (unknown), (unknown), Jens Lundgren	1
20	Viral toad changes in response to antiretroviral therapy according to the baseline CD4 lymphocyte count and viral load 2000 ·UCL Discovery (University College London) ·AN Phillips, S Staszewski, Rainer Weber, Ole Kirk, P Francioli, Miller, Pietro Vernazza, Jens Lundgren, Bruno Ledergerber	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact